These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 9294020)

  • 1. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure.
    Walker VE; Sisk SC; Upton PB; Wong BA; Recio L
    Mutat Res; 1997 Aug; 392(3):211-22. PubMed ID: 9294020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure.
    Sisk SC; Pluta LJ; Meyer KG; Wong BC; Recio L
    Mutat Res; 1997 Jul; 391(3):153-64. PubMed ID: 9268040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the mutagenic potency of 1,3-butadiene at the hprt locus of T-lymphocytes following inhalation exposure of female B6C3F1 mice and F344 rats.
    Meng Q; Recio L; Reilly AA; Wong BA; Bauer M; Walker VE
    Carcinogenesis; 1998 Jun; 19(6):1019-27. PubMed ID: 9667740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice.
    Walker VE; Gorelick NJ; Andrews JL; Craft TR; deBoer JG; Glickman BW; Skopek TR
    Cancer Res; 1996 Oct; 56(20):4654-61. PubMed ID: 8840980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cyclophosphamide-induced mutations at the Hprt but not the lacI locus in splenic lymphocytes of exposed mice.
    Walker VE; Andrews JL; Upton PB; Skopek TR; deBoer JG; Walker DM; Shi X; Sussman HE; Gorelick NJ
    Environ Mol Mutagen; 1999; 34(2-3):167-81. PubMed ID: 10529741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity at the Hprt locus in T cells of female mice following inhalation exposures to low levels of 1,3-butadiene.
    Meng Q; Henderson RF; Long L; Blair L; Walker DM; Upton PB; Swenberg JA; Walker VE
    Chem Biol Interact; 2001 Jun; 135-136():343-61. PubMed ID: 11397400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of HPRT mutations in splenic lymphocytes and haemoglobin adducts in erythrocytes of Lewis rats exposed to ethylene oxide.
    Tates AD; van Dam FJ; Natarajan AT; van Teylingen CM; de Zwart FA; Zwinderman AH; van Sittert NJ; Nilsen A; Nilsen OG; Zahlsen K; Magnusson AL; Törnqvist M
    Mutat Res; 1999 Dec; 431(2):397-415. PubMed ID: 10636004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity of 1,3-butadiene at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats.
    Meng Q; Henderson RF; Chen T; Heflich RH; Walker DM; Bauer MJ; Reilly AA; Walker VE
    Mutat Res; 1999 Aug; 429(1):107-25. PubMed ID: 10434027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
    Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
    Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between exposure, cell loss and proliferation, and manifestation of Hprt mutant T cells following treatment of preweanling, weanling, and adult male mice with N-ethyl-N-nitrosourea.
    Walker VE; Jones IM; Crippen TL; Meng Q; Walker DM; Bauer MJ; Reilly AA; Tates AD; Nakamura J; Upton PB; Skopek TR
    Mutat Res; 1999 Dec; 431(2):371-88. PubMed ID: 10636002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity of the racemic mixtures of butadiene monoepoxide and butadiene diepoxide at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats.
    Meng Q; Henderson RF; Walker DM; Bauer MJ; Reilly AA; Walker VE
    Mutat Res; 1999 Aug; 429(1):127-40. PubMed ID: 10434028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo mutagenicity and mutation spectrum in the bone marrow and testes of B6C3F1 lacI transgenic mice following inhalation exposure to ethylene oxide.
    Recio L; Donner M; Abernethy D; Pluta L; Steen AM; Wong BA; James A; Preston RJ
    Mutagenesis; 2004 May; 19(3):215-22. PubMed ID: 15123787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
    Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR
    Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of in vivo mutagenesis in the endogenous Hprt gene and the lacI transgene of Big Blue(R) rats treated with 7, 12-dimethylbenz[a]anthracene.
    Manjanatha MG; Shelton SD; Aidoo A; Lyn-Cook LE; Casciano DA
    Mutat Res; 1998 Jun; 401(1-2):165-78. PubMed ID: 9639698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative sensitivity of the endogenous hprt gene and lacI transgene in ENU-treated Big Blue B6C3F1 mice.
    Skopek TR; Kort KL; Marino DR
    Environ Mol Mutagen; 1995; 26(1):9-15. PubMed ID: 7641713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of exposure and effect as indicators of potential carcinogenic risk arising from in vivo metabolism of ethylene to ethylene oxide.
    Walker VE; Wu KY; Upton PB; Ranasinghe A; Scheller N; Cho MH; Vergnes JS; Skopek TR; Swenberg JA
    Carcinogenesis; 2000 Sep; 21(9):1661-9. PubMed ID: 10964097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo mutagenicity and mutational spectrum at the lacI transgene recovered from the spleens of B6C3F1 lacI transgenic mice following a 4-week inhalation exposure to 1,3-butadiene.
    Recio L; Pluta LJ; Meyer KG
    Mutat Res; 1998 Jun; 401(1-2):99-110. PubMed ID: 9639685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.